Russia Develops mRNA-Based Cancer Vaccine to Be Distributed Free of Cost by 2025
Russia’s Health Ministry has announced the development of an mRNA-based cancer vaccine designed to treat cancer patients rather than prevent the disease. According to Andrey Kaprin, General Director of the Radiology Medical Research Centre, the vaccine will be made available at no cost starting in early 2025. Pre-clinical trials have shown promising results, including suppression of tumor growth and reduced potential for metastases, as confirmed by Alexander Gintsburg, Director of the Gamaleya National Research Center.
Azerbaijan Airlines Embraer E190 Crashes Near Aktau, 42 Killed, 25 Survivors
Russian President Vladimir Putin had previously hinted at breakthroughs in cancer vaccines, describing them as part of a new generation of immunomodulatory drugs. While details on the targeted cancer types remain undisclosed, the vaccine signifies a major advancement in oncology. Other nations, like the UK and Germany, are also working on personalized cancer treatments, while pharmaceutical companies Moderna and Merck have developed an experimental melanoma vaccine showing a 50% reduction in recurrence or death over three years.
53 Years Since the Fall of Dhaka: A Wound That Still Bleeds
Russian researchers are employing artificial neural networks to accelerate the design of personalized cancer vaccines, reducing processing time from weeks to under an hour. The Ivannikov Institute, using AI-driven mathematical methods, is spearheading this innovation. This development positions Russia among the global frontrunners in the race to create transformative cancer therapies.
- China’s GWM Unveils New Bi-Turbo V8 Engine, Targets Luxury Car Market
- Nigeria has fully repaid its $3.4 billion International Monetary Fund (IMF) loan
- Covid-19 Cases Surge in Singapore and Taiwan, Authorities Urge Precaution
- Malaysia – Tragic Crash in Perak: 8 Police Officers Dead, 3 Seriously Injured
- Pakistan destroys India’s $1.5 billion S-400 air defence system in Adampur